Kymera Therapeutics
KYMR
KYMR
110 hedge funds and large institutions have $1.29B invested in Kymera Therapeutics in 2021 Q2 according to their latest regulatory filings, with 37 funds opening new positions, 45 increasing their positions, 16 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
13% more funds holding
Funds holding: 97 → 110 (+13)
8% more ownership
Funds ownership: 50.95% → 58.95% (+8%)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
Holders
110
Holding in Top 10
4
Calls
$7.47M
Puts
$48K
Top Buyers
| 1 | +$45.3M | |
| 2 | +$44.2M | |
| 3 | +$20.3M | |
| 4 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
+$19.9M |
| 5 |
State Street
Boston,
Massachusetts
|
+$19.4M |
Top Sellers
| 1 | -$20.6M | |
| 2 | -$15.5M | |
| 3 | -$13.9M | |
| 4 |
LGM
Logos Global Management
San Francisco,
California
|
-$10.1M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$8.24M |